SEC Form D · filed October 16, 2019
Carmell Therapeutics Corp
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
James F. Jordan · Pittsburgh, PADirectorRandolph Hubbell · Pittsburgh, PAExec · DirectorDavid W. Anderson · Pittsburgh, PADirectorDonna Godward · Pittsburgh, PAExecWendy W. Dicicco · Pittsburgh, PADirectorJames J. Hart · Hershey, PAExecRichard Upton · Pittsburgh, PADirectorStephanie W. Kladakis · Pittsburgh, PAExecJustin Fallon · Los Angeles, CADirectorChristian R. Cortis · Lexington, MAExecJay Venkatesan · Los Angeles, CAExecAlex R. Duncan · Lexington, MAExecEvan R. Kearns · Lexington, MADirectorFrances C. Hodler · CAMBRIDGE, MADirectorJames Connolly · Los Angeles, CAExec · DirectorMichael Meyers · Los Angeles, CADirectorAndrew W. Dym · New York, NYExecDavid W. Schiff · New York, NYDirectorJoseph W. Schottland · New York, NYDirectorMax Lin · MENLO PARK, CAExec · DirectorJim Momtazee · MENLO PARK, CAExecMark Bisso · HOUSTON, TXExecAndrew J. Duffy · New York, NYDirectorJefry A. Baker · Portland, ORDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗